Login Register
English
0

Cart

$ 0

CheKine™ Micro Albumin Content Assay Kit: Why the BCG Method Outperforms Immunoassays for Routine Albumin Quantification

Date:2026-08-25 Views:20

Albumin: The Most Abundant Plasma Protein and Critical Clinical Biomarker

Albumin is the most abundant protein in plasma, accounting for approximately 60% of total plasma protein. It serves as a carrier for hormones, fatty acids, and drugs, maintains oncotic pressure, and functions as a key antioxidant. Albumin levels are critical biomarkers for liver function, kidney health, nutritional status, and inflammation. Hypoalbuminemia is associated with liver cirrhosis, nephrotic syndrome, malnutrition, and chronic inflammatory conditions.

Why Abbkine KTB2221 Stands Out

FeatureAbbkine KTB2221Traditional ImmunoassaysTraditional BCG Kits
Detection PrincipleBromocresol Green (BCG) dye-bindingAntibody-based (ELISA, immunoturbidimetry)BCG dye-binding
Sample VolumeMicro-scale (5–10 µL)50–100 µL20–50 µL
Assay Time~10–15 minutes1–3 hours20–30 minutes
SpecificityOptimized for albuminHigh (antibody-specific)Variable; globulin interference
CostLowHighModerate
Throughput96-well microplateLow to moderateModerate

The BCG Dye-Binding Advantage

Bromocresol Green (BCG) binds specifically to albumin at a defined pH, producing a color change that is quantified spectrophotometrically. Compared to immunoassays (ELISA, immunoturbidimetry)—which require antibodies, multiple incubation steps, and extended assay times—BCG-based methods offer a rapid, cost-effective alternative for routine albumin quantification. The CheKine™ Micro Albumin Content Assay Kit optimizes the BCG method for microplate format, delivering results in under 15 minutes with minimal sample consumption.

Why Traditional BCG Kits Fall Short

Classic BCG-based albumin assays suffer from interference from globulins, bilirubin, and hemoglobin—leading to overestimation of albumin by up to 15–20% in certain samples. KTB2221 uses a proprietary modified BCG chromogenic system, optimized at a specific pH to minimize interference from globulins and other serum proteins. This ensures accurate albumin quantification even in complex biological matrices.

Applications Across Research Fields

  • Hepatology — monitoring albumin synthesis in liver fibrosis, cirrhosis, and hepatocellular carcinoma
  • Nephrology — assessing albuminuria in diabetic nephropathy and glomerular damage
  • Nutritional Research — evaluating protein-energy malnutrition and wasting syndromes
  • Inflammatory Disease — tracking albumin as a negative acute-phase protein
  • Drug Development — studying drug-albumin binding and pharmacokinetics
  • Veterinary Science — monitoring albumin levels in animal models

The Micro-Scale Advantage for Precious Samples

The micro-scale format requires only 5–10 µL of sample per assay—ideal for pediatric samples, rare clinical specimens, primary cell supernatants, and small-animal serum. This design preserves precious biological material while enabling high-throughput screening in 96-well plate format.

Critical Sample Handling Tips

  • Serum/plasma: Use fresh samples; avoid hemolysis, which can interfere with readings
  • Storage: If not assayed immediately, store at -80°C for up to one month
  • Standards: Always include albumin standards for accurate quantification
  • Dilution: Dilute samples if readings exceed the standard curve range

The Bottom Line

For researchers who need rapid, reliable albumin quantification without the cost and complexity of immunoassays, KTB2221 delivers the specificity, speed, and micro-scale efficiency that modern translational research demands.

👉 Quantify albumin with confidence. View Product